- Home
- CLIR vs PULM Comparison
CLIR vs PULM Comparison
Compare CLIR & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- PULM
- Stock Information
- Founded
- CLIR 2008
- PULM 2003
- Country
- CLIR United States
- PULM United States
- Employees
- CLIR N/A
- PULM N/A
- Industry
- CLIR Industrial Machinery/Components
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- PULM Health Care
- Exchange
- CLIR Nasdaq
- PULM Nasdaq
- Market Cap
- CLIR 27.9M
- PULM 33.2M
- IPO Year
- CLIR 2012
- PULM N/A
- Fundamental
- Price
- CLIR $0.53
- PULM $6.21
- Analyst Decision
- CLIR Strong Buy
- PULM
- Analyst Count
- CLIR 1
- PULM 0
- Target Price
- CLIR $2.00
- PULM N/A
- AVG Volume (30 Days)
- CLIR 54.6K
- PULM 58.4K
- Earning Date
- CLIR 08-13-2025
- PULM 08-12-2025
- Dividend Yield
- CLIR N/A
- PULM N/A
- EPS Growth
- CLIR N/A
- PULM N/A
- EPS
- CLIR N/A
- PULM N/A
- Revenue
- CLIR $2,895,000.00
- PULM $1,921,000.00
- Revenue This Year
- CLIR $27.61
- PULM N/A
- Revenue Next Year
- CLIR $116.19
- PULM $134.88
- P/E Ratio
- CLIR N/A
- PULM N/A
- Revenue Growth
- CLIR 10.88
- PULM N/A
- 52 Week Low
- CLIR $0.46
- PULM $1.78
- 52 Week High
- CLIR $1.72
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- CLIR 40.91
- PULM 41.72
- Support Level
- CLIR $0.50
- PULM $6.28
- Resistance Level
- CLIR $0.60
- PULM $6.83
- Average True Range (ATR)
- CLIR 0.05
- PULM 0.44
- MACD
- CLIR -0.00
- PULM -0.05
- Stochastic Oscillator
- CLIR 35.73
- PULM 13.89
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).